Guidance for industry. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. http://www.fda.gov/cder/guidance/5541fnl.pdf
COLLINS, JM. Potential roles for preclinical pharmacology in phase I clinical trials. Cancer Treat Rep. 1986, 70, 73-80